Company: INMB
Filing Date: 2025-03-07
Form Type: 424B5
Source: 0001213900-25-021719
Chunk: 22

Company: Inmune Bio, Inc.
Filing Date: 2025-03-07
Form: 424B5
Chunk 22
---
 at the option of each holder, in whole or in part, by delivering a duly executed
exercise notice accompanied by payment in full for the number of purchased upon such exercise (except in the case of a cashless exercise
as discussed below). A holder (together with its affiliates) may not exercise any portion of the September 2024 Warrant to the extent
that the holder would own more than 4.99% (or, at the election of a purchaser, 9.99%) of the outstanding common stock immediately after
exercise, except that upon at least 61 days’ prior notice from the holder to us, the holder may increase the amount of ownership
of outstanding common stock after exercising the holder’s September 2024 Warrants up to 9.99% of the number of shares of common
stock outstanding immediately after giving effect to the exercise, as such percentage ownership is determined in accordance with the terms
of the September 2024 Warrants. No fractional shares of common stock will be issued in connection with the exercise of the September 2024
Warrant. In lieu of fractional shares, we will pay the holder an amount in cash equal to the fractional amount multiplied by the exercise
price.

Insider Participation

In the September 2024 Offering,
certain of our officers and directors and employees purchased the September 2024 Warrants sold on the same terms as described herein,
except that (i) the combined offering price per share of common stock and accompanying September 2024 Warrant for officers and directors
was $6.50 and (ii) in the event that the September 2024 Warrant is held by our directors, officers or other affiliates and the termination
date is during a period that such officers, directors or affiliates are subject to a blackout with respect to trading in our common stock,
such officers or affiliates will have an additional 60 days from the termination of the blackout date to exercise the September 2024 Warrants.

<div align='center'>S-10

PLAN OF DISTRIBUTION</div>

We are directly offering the
shares of common stock issuable upon exercise of the Warrants to the holders thereof upon exercise of such holders from time to time until
the expiration date of the Warrants.

The sale of securities
offered by this prospectus supplement may be completed from time to time upon the exercise of the Warrants by the holders thereof.
Upon the exercise of the Warrants, The Depository Trust Company will credit the shares of common stock iss